title: Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Maria
authors.initials: M
authors.lastname: Gavriatopoulou
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Efstathios
authors.initials: E
authors.lastname: Kastritis
authors.affiliation: b Laikon Hospital , National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Kyrtsonis
authors.affiliation: b Laikon Hospital , National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Theodoros P
authors.initials: TP
authors.lastname: Vassilakopoulos
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Maria
authors.initials: M
authors.lastname: Roussou
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Despoina
authors.initials: D
authors.lastname: Fotiou
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Magdalini
authors.initials: M
authors.lastname: Migkou
authors.affiliation: c Evaggelismos General Hospital , Athens , Greece.
authors.forename: Maria
authors.initials: M
authors.lastname: Mpakiri
authors.affiliation: c Evaggelismos General Hospital , Athens , Greece.
authors.forename: Anna
authors.initials: A
authors.lastname: Tasidou
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Terpos
authors.affiliation: a Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
authors.forename: Meletios Athanasios
authors.initials: MA
authors.lastname: Dimopoulos
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D006801:Humans; D012008:Recurrence; D019233:Retreatment; D016019:Survival Analysis; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003520:Cyclophosphamide; D014740:Vidarabine; C527517:ofatumumab; C024352:fludarabine